Literature DB >> 8163699

CA 125 secretion by peritoneal mesothelial cells.

A M Zeillemaker1, H A Verbrugh, A A Hoynck van Papendrecht, P Leguit.   

Abstract

AIMS: To investigate the secretion of the tumour marker CA 125 by cultured human mesothelial cells; to determine if secretion of CA 125 could be observed by activating the mesothelial monolayers with different cytokines.
METHODS: Mesothelial cells were isolated from human omentum and cultured to confluent monolayers on perforated polycarbonate membranes (pore size 0.4 micron). The mesothelial monolayers were activated and the apical and basolateral secretion of CA 125 compared. To investigate the influence of cytokines, mesothelial cells were cultured and activated with recombinant interleukin-1 beta (rIL-1 beta), tumour necrosis factor-alpha (TNF-alpha) or lipopolysaccharide from Escherichia coli. The secretion of CA 125 was tested using a microparticle enzyme immunoassay.
RESULTS: Mesothelial monolayers secreted CA 125 in a polarised manner with preference for the apical side. Apical polarisation occurred irrespective of the side of the inducing stimulus (p < or = 0.05). Non-activated cultured mesothelial monolayers secreted significant quantities of CA 125, indicating constitutive production of this protein. However, CA 125 production was significantly enhanced if mesothelial cells were incubated with rIL-1 beta (p < or = 0.05), TNF-alpha (p < or = 0.05), and E coli LPS (p < or = 0.01).
CONCLUSIONS: Human mesothelial monolayers secrete CA 125 preferentially from their apical surfaces. The secretion of CA 125 can be enhanced by the inflammatory cytokines Il-1 beta, TNF-alpha, and by E coli LPS.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8163699      PMCID: PMC501908          DOI: 10.1136/jcp.47.3.263

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  17 in total

1.  Elevation of CA 125 in patients with benign and malignant ascites.

Authors:  J F Bergmann; J M Bidart; M George; M Beaugrand; V G Levy; C Bohuon
Journal:  Cancer       Date:  1987-01-15       Impact factor: 6.860

2.  Explanation of the limited correlation between tumor CA 125 content and serum CA 125 antigen levels in patients with ovarian tumors.

Authors:  G J Fleuren; M Nap; J G Aalders; J B Trimbos; H W de Bruijn
Journal:  Cancer       Date:  1987-11-15       Impact factor: 6.860

3.  Preoperative evaluation of serum CA 125 levels in patients with primary epithelial ovarian cancer.

Authors:  N Einhorn; R C Bast; R C Knapp; B Tjernberg; V R Zurawski
Journal:  Obstet Gynecol       Date:  1986-03       Impact factor: 7.661

4.  Tissue distribution of a coelomic-epithelium-related antigen recognized by the monoclonal antibody OC125.

Authors:  S E Kabawat; R C Bast; A K Bhan; W R Welch; R C Knapp; R B Colvin
Journal:  Int J Gynecol Pathol       Date:  1983       Impact factor: 2.762

5.  Regulation of the cytoskeleton in mesothelial cells: reversible loss of keratin and increase in vimentin during rapid growth in culture.

Authors:  N D Connell; J G Rheinwald
Journal:  Cell       Date:  1983-08       Impact factor: 41.582

6.  Tuberculous peritonitis with extraordinarily high serum CA125.

Authors:  K Okazaki; K Mizuno; K Katoh; S Hashimoto; S Fukuchi
Journal:  J Med       Date:  1992

7.  A radioimmunoassay using a monoclonal antibody to monitor the course of epithelial ovarian cancer.

Authors:  R C Bast; T L Klug; E St John; E Jenison; J M Niloff; H Lazarus; R S Berkowitz; T Leavitt; C T Griffiths; L Parker; V R Zurawski; R C Knapp
Journal:  N Engl J Med       Date:  1983-10-13       Impact factor: 91.245

8.  Ovarian cancer antigen CA 125 levels in pelvic inflammatory disease and pregnancy.

Authors:  H Halila; U H Stenman; M Seppälä
Journal:  Cancer       Date:  1986-04-01       Impact factor: 6.860

9.  Reactivity of a monoclonal antibody with human ovarian carcinoma.

Authors:  R C Bast; M Feeney; H Lazarus; L M Nadler; R B Colvin; R C Knapp
Journal:  J Clin Invest       Date:  1981-11       Impact factor: 14.808

10.  Ovarian cancer antigen CA125: a prospective clinical assessment of its role as a tumour marker.

Authors:  P A Canney; M Moore; P M Wilkinson; R D James
Journal:  Br J Cancer       Date:  1984-12       Impact factor: 7.640

View more
  26 in total

1.  Re: Cancer antigen 125 as a biomarker in peritoneal dialysis: mesothelial cell health or death?

Authors:  J M Bargman
Journal:  Perit Dial Int       Date:  2013 Nov-Dec       Impact factor: 1.756

2.  Cancer antigen 125 as a biomarker in peritoneal dialysis: mesothelial cell health or death?

Authors:  R T Krediet
Journal:  Perit Dial Int       Date:  2013 Nov-Dec       Impact factor: 1.756

Review 3.  Clinical utility of antigen carbohydrate 125 in heart failure.

Authors:  Julio Núñez; Gema Miñana; Eduardo Núñez; Francisco J Chorro; Vicent Bodí; Juan Sanchis
Journal:  Heart Fail Rev       Date:  2014-09       Impact factor: 4.214

4.  Limited influence of the mesothelium on the influx of monocytes into the peritoneal cavity.

Authors:  A M Zeillemaker; F P Mul; A A Van Papendrecht; P Leguit; H A Verbrugh; D Roos
Journal:  Inflammation       Date:  1996-02       Impact factor: 4.092

Review 5.  Red Snappers and Red Herrings: Pelvic Tuberculosis Causing Elevated CA 125 and Mimicking Advanced Ovarian Cancer. A Case Report and Literature Review.

Authors:  Johnnie Alphonse Yates; Olivia Ann Collis; Thanasak Sueblinvong; Tarquin Kamakana Collis
Journal:  Hawaii J Med Public Health       Date:  2017-08

6.  Dialysate CA125 levels in children on continuous peritoneal dialysis.

Authors:  Pinar Turhan; Lale Sever; Salim Caliskan; Ozgur Kasapcopur; Ayse Sever; Munire Hacibekiroglu; Nil Arisoy
Journal:  Pediatr Nephrol       Date:  2005-08-20       Impact factor: 3.714

7.  Benign lymph node inclusions mimicking metastatic carcinoma.

Authors:  A G Douglas-Jones
Journal:  J Clin Pathol       Date:  1994-09       Impact factor: 3.411

8.  Polarized secretion of interleukin-8 by human mesothelial cells: a role in neutrophil migration.

Authors:  A M Zeillemaker; F P Mul; A A Hoynck van Papendrecht; T W Kuijpers; D Roos; P Leguit; H A Verbrugh
Journal:  Immunology       Date:  1995-02       Impact factor: 7.397

9.  Cancer antigen 125 levels in inflammatory bowel diseases.

Authors:  Hilmi Ataseven; Zeynel Abidin Oztürk; Mehmet Arhan; Osman Yüksel; Seyfettin Köklü; Mehmet Ibiş; Omer Başar; Fatma Meriç Yilmaz; Ilhami Yüksel
Journal:  J Clin Lab Anal       Date:  2009       Impact factor: 2.352

10.  Influence of tumor grade on expression of CA 125 in serum and tissue in patients with serous ovarian carcinoma.

Authors:  Igor But
Journal:  Wien Klin Wochenschr       Date:  2003-04-30       Impact factor: 1.704

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.